Sean Brusky - Pardes Biosciences Chief Officer
| PRDSDelisted Stock | USD 2.14 0.01 0.47% |
Insider
Sean Brusky is Chief Officer of Pardes Biosciences
| Age | 45 |
| Phone | 415 649 8758 |
| Web | https://www.pardesbio.com |
Sean Brusky Latest Insider Activity
Tracking and analyzing the buying and selling activities of Sean Brusky against Pardes Biosciences stock is an integral part of due diligence when investing in Pardes Biosciences. Sean Brusky insider activity provides valuable insight into whether Pardes Biosciences is net buyers or sellers over its current business cycle. Note, Pardes Biosciences insiders must abide by specific rules, including filing SEC forms every time they buy or sell Pardes Biosciences'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Sean Brusky over a year ago Acquisition by Sean Brusky of 156250 shares of Pardes Biosciences subject to Rule 16b-3 |
Pardes Biosciences Management Efficiency
The company has return on total asset (ROA) of (0.2649) % which means that it has lost $0.2649 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4028) %, meaning that it created substantial loss on money invested by shareholders. Pardes Biosciences' management efficiency ratios could be used to measure how well Pardes Biosciences manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| James JD | Eliem Therapeutics | 58 | |
| Tharaknath Rao | Assembly Biosciences | N/A | |
| Robert Bazemore | Nuvation Bio | 53 | |
| DSc FACP | Ovid Therapeutics | 65 | |
| Julia Wilson | Achilles Therapeutics PLC | N/A | |
| MPH MD | Connect Biopharma Holdings | 54 | |
| Gregory Russotti | Century Therapeutics | 57 | |
| Michelle Doig | Nuvation Bio | 46 | |
| Dr IV | Assembly Biosciences | 52 | |
| Casi DeYoung | Shattuck Labs | 53 | |
| Claude MD | Ovid Therapeutics | 71 | |
| Abhinav Shukla | Shattuck Labs | ||
| DPHIL DPhil | CytomX Therapeutics | 57 | |
| Mark Dudley | Instil Bio | N/A | |
| Kim Blickenstaff | Nuvation Bio | 68 | |
| W Vernon | Nuvation Bio | 65 | |
| Michele Anderson | Assembly Biosciences | N/A | |
| Stacy Markel | Nuvation Bio | 59 | |
| Fatima MD | Shattuck Labs | N/A | |
| Sergey Yurasov | Nuvation Bio | 51 | |
| Raul Collazo | Connect Biopharma Holdings | N/A | |
Management Performance
| Return On Equity | -0.4 | |||
| Return On Asset | -0.26 |
Pardes Biosciences Leadership Team
Elected by the shareholders, the Pardes Biosciences' board of directors comprises two types of representatives: Pardes Biosciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Pardes. The board's role is to monitor Pardes Biosciences' management team and ensure that shareholders' interests are well served. Pardes Biosciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Pardes Biosciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Elizabeth JD, Gen Sec | ||
| Heidi CPA, Chief Officer | ||
| Dave Kuo, VP HR | ||
| Uri MD, Founder Director | ||
| Valdas Jurkauskas, VP Operations | ||
| Thomas Wiggans, CEO Chairman | ||
| Patrick OBrien, VP Relations | ||
| Sean Brusky, Chief Officer | ||
| Brian PharmD, Chief Officer | ||
| Ann Kwong, Ex Research |
Pardes Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Pardes Biosciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.4 | |||
| Return On Asset | -0.26 | |||
| Current Valuation | (22.1 M) | |||
| Shares Outstanding | 62.01 M | |||
| Shares Owned By Insiders | 13.47 % | |||
| Shares Owned By Institutions | 72.05 % | |||
| Number Of Shares Shorted | 874.35 K | |||
| Price To Book | 0.37 X | |||
| EBITDA | (99.82 M) | |||
| Net Income | (96.63 M) |
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Pardes Stock
If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |